1
|
Markham TE, Codd R. A Mild and Modular Approach to the Total Synthesis of Desferrioxamine B. J Org Chem 2024; 89:5118-5125. [PMID: 38471001 PMCID: PMC11003418 DOI: 10.1021/acs.joc.3c02739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2023] [Revised: 02/22/2024] [Accepted: 02/28/2024] [Indexed: 03/14/2024]
Abstract
A mild and modular approach to the total synthesis of the WHO-listed essential medicine desferrioxamine B is described. Hydroxamic acid fragments were installed under mild conditions, a generalized divergent acylation procedure used to access two monomer precursors, and a transfer hydrogenation reaction used to unmask the hydroxamic acid moieties. Desferrioxamine B was generated over ten linear steps as the formate salt in 17% overall yield using standard amide coupling conditions or in 13% overall yield using microwave-assisted amide coupling conditions.
Collapse
Affiliation(s)
- Todd E. Markham
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Rachel Codd
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
2
|
Randhawa P, Carbo-Bague I, Davey PRWJ, Chen S, Merkens H, Uribe CF, Zhang C, Tosato M, Bénard F, Radchenko V, Ramogida CF. Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals. Front Chem 2024; 12:1292566. [PMID: 38389726 PMCID: PMC10881723 DOI: 10.3389/fchem.2024.1292566] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Accepted: 01/23/2024] [Indexed: 02/24/2024] Open
Abstract
A comprehensive investigation of the Hg2+ coordination chemistry and 197m/gHg radiolabeling capabilities of cyclen-based commercial chelators, namely, DOTA and DOTAM (aka TCMC), along with their bifunctional counterparts, p-SCN-Bn-DOTA and p-SCN-Bn-TCMC, was conducted to assess the suitability of these frameworks as bifunctional chelators for the 197m/gHg2+ theranostic pair. Radiolabeling studies revealed that TCMC and DOTA exhibited low radiochemical yields (0%-6%), even when subjected to harsh conditions (80°C) and high ligand concentrations (10-4 M). In contrast, p-SCN-Bn-TCMC and p-SCN-Bn-DOTA demonstrated significantly higher 197m/gHg radiochemical yields (100% ± 0.0% and 70.9% ± 1.1%, respectively) under the same conditions. The [197 m/gHg]Hg-p-SCN-Bn-TCMC complex was kinetically inert when challenged against human serum and glutathione. To understand the differences in labeling between the commercial chelators and their bifunctional counterparts, non-radioactive natHg2+ complexes were assessed using NMR spectroscopy and DFT calculations. The NMR spectra of Hg-TCMC and Hg-p-SCN-Bn-TCMC suggested binding of the Hg2+ ion through the cyclen backbone framework. DFT studies indicated that binding of the Hg2+ ion within the backbone forms a thermodynamically stable product. However, competition can form between isothiocyanate binding and binding through the macrocycle, which was experimentally observed. The isothiocyanate bound coordination product was dominant at the radiochemical scale as, in comparison, the macrocycle bound product was seen at the NMR scale, agreeing with the DFT result. Furthermore, a bioconjugate of TCMC (TCMC-PSMA) targeting prostate-specific membrane antigen was synthesized and radiolabeled, resulting in an apparent molar activity of 0.089 MBq/nmol. However, the complex demonstrated significant degradation over 24 h when exposed to human serum and glutathione. Subsequently, cell binding assays were conducted, revealing a Ki value ranging from 19.0 to 19.6 nM. This research provides crucial insight into the effectiveness of current commercial chelators in the context of 197m/gHg2+ radiolabeling. It underscores the necessity for the development of specific and customized chelators to these unique "soft" radiometals to advance 197m/gHg2+ radiopharmaceuticals.
Collapse
Affiliation(s)
- Parmissa Randhawa
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| | - Imma Carbo-Bague
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| | - Patrick R W J Davey
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| | - Shaohuang Chen
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| | - Helen Merkens
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Carlos F Uribe
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Chengcheng Zhang
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Marianna Tosato
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| | - François Bénard
- Department of Molecular Oncology, BC Cancer, Vancouver, BC, Canada
| | - Valery Radchenko
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
- Department of Chemistry, University of British Columbia, Vancouver, BC, Canada
| | - Caterina F Ramogida
- Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada
- Life Sciences Division, TRIUMF, Vancouver, BC, Canada
| |
Collapse
|
3
|
Guarrochena X, Kronberger J, Tieber M, Ciesielski P, Mindt TL, Feiner IVJ. Straightforward Synthesis of DFO* - An Octadentate Chelator for Zirconium-89. ChemMedChem 2024; 19:e202300495. [PMID: 38102942 DOI: 10.1002/cmdc.202300495] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Revised: 12/11/2023] [Accepted: 12/15/2023] [Indexed: 12/17/2023]
Abstract
DFO* is an octadentate chelator able to form highly stable chelates with Zirconium-89 (89 Zr) for nuclear medicinal applications in Positron Emission Tomography (PET).[1,2] The synthesis of DFO* and its scale-up remains challenging by reported synthetic protocols. For this reason, we set out to develop a de novo synthesis of a hydroxamate-containing building block suitable for the coupling to the commercially available DFO (desferrioxamine B, mesylate salt) yielding, after deprotection, the desired chelator DFO* in a more efficient procedure. Highlights of the new synthesis of DFO* reported herein are less synthetic steps and the isolation of the desired product DFO* by using solid phase extraction (SPE), thus avoiding tedious HPLC purification. DFO* is obtained in excellent purity (92-98 %) and an overall yield of approximately 29 %. In addition, the isolated trifluoroacetic acid (TFA)-salt of DFO* displays an improved solubility in organic solvents (DMSO, DMF, methanol), which will facilitate its use for the preparation of structurally diverse derivatives suitable for bioconjugation chemistry and the development of 89 Zr-labeled radiotracers.
Collapse
Affiliation(s)
- Xabier Guarrochena
- Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Vienna Doctoral School in Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Waehringer Guertel 18-20, 1090, Vienna, Austria
- Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria
| | - Julia Kronberger
- Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Vienna Doctoral School in Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Waehringer Guertel 18-20, 1090, Vienna, Austria
- Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria
| | - Manuel Tieber
- Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
| | - Philipp Ciesielski
- ABX Advanced Biochemical Compounds, Heinrich-Glaeser-Strasse 10-14, 01454 Radeberg, Germany
| | - Thomas L Mindt
- Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Waehringer Guertel 18-20, 1090, Vienna, Austria
- Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria
- Joint Applied Medicinal Radiochemistry Facility, University of Vienna and Medical University of Vienna, Vienna, Austria
| | - Irene V J Feiner
- Bioinorganic Radiochemistry, Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Strasse 42, 1090, Vienna, Austria
- Ludwig Boltzmann Institute Applied Diagnostics, AKH Wien c/o Sekretariat Nuklearmedizin, Waehringer Guertel 18-20, 1090, Vienna, Austria
- Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria
| |
Collapse
|
4
|
Nolan KP, Font J, Sresutharsan A, Gotsbacher MP, Brown CJM, Ryan RM, Codd R. Acetyl-CoA-Mediated Post-Biosynthetic Modification of Desferrioxamine B Generates N- and N- O-Acetylated Isomers Controlled by a pH Switch. ACS Chem Biol 2022; 17:426-437. [PMID: 35015506 DOI: 10.1021/acschembio.1c00879] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Biosynthesis of the hydroxamic acid siderophore desferrioxamine D1 (DFOD1, 6), which is the N-acetylated analogue of desferrioxamine B (DFOB, 5), has been delineated. Enzyme-independent Ac-CoA-mediated N-acetylation of 5 produced 6, in addition to three constitutional isomers containing an N-O-acetyl group installed at either one of the three hydroxamic acid groups of 5. The formation of N-Ac-DFOB (DFOD1, 6) and the composite of N-O-acetylated isomers N-O-Ac-DFOB[001] (6a), N-O-Ac-DFOB[010] (6b), and N-O-Ac-DFOB[100] (6c) (defined as the N-O-Ac motif positioned within the terminal amine, internal, or N-acetylated region of 5, respectively), was pH-dependent, with 6a-6c dominant at pH < 8.5 and 6 dominant at pH > 8.5. The trend in the pH dependence was consistent with the pKa values of the NH3+ (pKa ∼ 10) and N-OH (pKa ∼ 8.5-9) groups in 5. The N- and N-O-acetyl motifs can be conceived as a post-biosynthetic modification (PBM) of a nonproteinaceous secondary metabolite, akin to a post-translational modification (PTM) of a protein. The pH-labile N-O-acetyl group could act as a reversible switch to modulate the properties and functions of secondary metabolites, including hydroxamic acid siderophores. An alternative (most likely minor) biosynthetic pathway for 6 showed that the nonribosomal peptide synthetase-independent siderophore synthetase DesD was competent in condensing N'-acetyl-N-succinyl-N-hydroxy-1,5-diaminopentane (N'-Ac-SHDP, 7) with the dimeric hydroxamic acid precursor (AHDP-SHDP, 4) native to 5 biosynthesis to generate 6. The strategy of diversifying protein structure and function using PTMs could be paralleled in secondary metabolites with the use of PBMs.
Collapse
Affiliation(s)
- Kate P. Nolan
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Josep Font
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Athavan Sresutharsan
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Michael P. Gotsbacher
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Christopher J. M. Brown
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Renae M. Ryan
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Rachel Codd
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia
| |
Collapse
|
5
|
Shioiri T, Ishihara K, Matsugi M. Cutting edge of diphenyl phosphorazidate (DPPA) as a synthetic reagent – A fifty-year odyssey. Org Chem Front 2022. [DOI: 10.1039/d2qo00403h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Recent developments of diphenyl phosphorazidate (DPPA, (C6H5O)2P(O)N3) has been reviewed.
Collapse
Affiliation(s)
- Takayuki Shioiri
- Faculty of Agriculture, Meijo University, Shiogamaguchi, Tempaku, Nagoya 468-8502, Japan
| | - Kotaro Ishihara
- Faculty of Agriculture, Meijo University, Shiogamaguchi, Tempaku, Nagoya 468-8502, Japan
| | - Masato Matsugi
- Faculty of Agriculture, Meijo University, Shiogamaguchi, Tempaku, Nagoya 468-8502, Japan
| |
Collapse
|
6
|
Brown CJM, Codd R. Directing macrocyclic architecture using iron(III)-, gallium(III)-, or zirconium(IV)-assisted ring closure of linear dimeric endo-hydroxamic acid ligands. J Inorg Biochem 2020; 216:111337. [PMID: 33360106 DOI: 10.1016/j.jinorgbio.2020.111337] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 11/11/2020] [Accepted: 12/04/2020] [Indexed: 11/17/2022]
Abstract
Dimeric hydroxamic acid macrocycles are a subclass of bacterial siderophores produced for iron acquisition. Limited yields from natural sources provides the impetus to develop synthetic routes to improve access to these compounds, which have potential utility in metal ion binding applications in the environment and medicine. This work has examined the role of metal ions in forming pre-complexes with linear endo-hydroxamic acid (endo-HXA) ligands bearing terminal amine and carboxylic acid groups optimally configured for in situ ring closure reactions. The 1:1 reaction between Fe(III) and the dimeric endo-HXA ligand 5-((5-(5-((5-aminopentyl)(hydroxy)amino)-5-oxopentanamido)pentyl)(hydroxy)amino)-5-oxopentanoic acid (PPH-PPH) (1) formed the pre-complex (PC) [Fe(PP-PP)-PC]+ with in situ amide coupling generating the macrocycle (MC) [Fe(PP)2-MC]+ and, following Fe(III) removal, the apo-macrocycle 1,13-dihydroxy-1,7,13,19-tetraazacyclotetracosane-2,6,14,18-tetraone (PPH)2-MC (2). The 1:2 reaction system between Fe(III) and the monomeric endo-HXA ligand 5-((5-aminopentyl)(hydroxy)amino)-5-oxopentanoic acid (PPH) gave significantly less [Fe(PP)2-MC]+ than the former system, due to the requirement to form two rather than one amide bond(s). The 1:1 Ga(III):1 system yielded [Ga(PP-PP)-PC]+ and [Ga(PP)2-MC]+. Neither [Zr(PP-PP)-PC]2+ nor [Zr(PP)2-MC]2+ was detected in the 1:1 Zr(IV):1 system. Instead, the Zr(IV) system showed the formation of a 1:2 Zr(IV):1 pre-complex [Zr(PP-PP)2-PC], which following in situ amide bond forming chemistry, generated two Zr(IV) macrocyclic complexes with distinct architectures: a dimer-of-dimers complex [Zr((PP)2)2-MC] and an end-to-end macrocycle [Zr(PP)4-MC]. The formation of [Fe(PP)2-MC]+, [Ga(PP)2-MC]+ or [Zr((PP)2)2-MC] was confirmed from reconstitution experiments with 2. The work has shown that the choice of metal ion in metal-assisted ring closure reactions directs the assembly of macrocyclic complexes with distinct architectures.
Collapse
Affiliation(s)
- Christopher J M Brown
- The University of Sydney, School of Medical Sciences (Pharmacology), New South Wales 2006, Australia
| | - Rachel Codd
- The University of Sydney, School of Medical Sciences (Pharmacology), New South Wales 2006, Australia.
| |
Collapse
|
7
|
Chiu C, Jheng T, Peng B, Chung W, Mong KT. Convergent Synthesis of Macrocyclic and Linear Desferrioxamines. European J Org Chem 2020. [DOI: 10.1002/ejoc.202000439] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Cheng‐Hsin Chiu
- Applied Chemistry Department National Chiao Tung University 1001, University Road R.O.C. 30069 Hsinchu City Taiwan
| | - Ting‐Cian Jheng
- Applied Chemistry Department National Chiao Tung University 1001, University Road R.O.C. 30069 Hsinchu City Taiwan
| | - Bo‐Chun Peng
- Applied Chemistry Department National Chiao Tung University 1001, University Road R.O.C. 30069 Hsinchu City Taiwan
| | - Wen‐Sheng Chung
- Applied Chemistry Department National Chiao Tung University 1001, University Road R.O.C. 30069 Hsinchu City Taiwan
| | - Kwok‐Kong Tony Mong
- Applied Chemistry Department National Chiao Tung University 1001, University Road R.O.C. 30069 Hsinchu City Taiwan
| |
Collapse
|
8
|
Abstract
The thermodynamic stability of a metal-ligand complex, as measured by the formation constant (log β), is one of the most important parameters that determines metal ion selectivity and potential applications in, for example, radiopharmaceutical science. The stable coordination chemistry of radioactive 89Zr4+ in an aqueous environment is of paramount importance when developing positron-emitting radiotracers based on proteins (usually antibodies) for use with positron emission tomography. Desferrioxamine B (DFO) remains the chelate of choice for clinical applications of 89Zr-labeled proteins, but the coordination of DFO to Zr4+ ions is suboptimal. Many alternative ligands have been reported, but the challenges in measuring very high log β values with metal ions such as Zr4+ that tend to hydrolyze mean that accurate thermodynamic data are scarce. In this work, density functional theory (DFT) calculations were used to predict the reaction energetics for metal ion complexation. Computed values of pseudoformation constants (log β') are correlated with experimental data and showed an excellent linear relationship (R2 = 0.97). The model was then used to estimate the absolute and relative formation constants of 23 different Zr4+ complexes using a total of 17 different ligands, including many of the alternative bifunctional chelates that have been reported recently for use in 89Zr4+ radiochemistry. In addition, detailed computational studies were performed on the geometric isomerism and hydration state of Zr-desferrioxamine. Collectively, the results offer new insights into Zr4+ coordination chemistry that will help guide the synthesis of future ligands. The computational model developed here is straightforward and reproducible and can be readily applied in the design of other metal coordination compounds.
Collapse
Affiliation(s)
- Jason P Holland
- University of Zurich , Department of Chemistry , Winterthurerstrasse 190 , CH-8057 Zurich , Switzerland
| |
Collapse
|